Adrian C. Newland

Turner Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases.

Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases.

Journal: Expert review of clinical immunology

Published: April 29, 2025

Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment.

Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment.

Journal: Blood reviews

Published: April 21, 2024

Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in The Netherlands (TRAPeze Netherlands study).

Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in The Netherlands (TRAPeze Netherlands study).

Journal: Hematology (Amsterdam, Netherlands)

Published: October 11, 2023

Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort.

Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 08, 2023

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: May 05, 2023

Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View.

Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal View.

Journal: Medicina (Kaunas, Lithuania)

Published: March 01, 2023

Investigational drugs for immune thrombocytopenia.

Investigational drugs for immune thrombocytopenia.

Journal: Expert opinion on investigational drugs

Published: May 09, 2022

Incidence of adult primary immune thrombocytopenia in England-An update.

Incidence of adult primary immune thrombocytopenia in England-An update.

Journal: European journal of haematology

Published: December 20, 2021

Immune thrombocytopenia.

Immune thrombocytopenia.

Journal: Expert review of hematology

Published: November 01, 2021

Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study).

Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study).

Journal: Hematology (Amsterdam, Netherlands)

Published: October 04, 2021

Experts' review: the emerging roles of romiplostim in immune thrombocytopenia (ITP).

Experts' review: the emerging roles of romiplostim in immune thrombocytopenia (ITP).

Journal: Expert opinion on biological therapy

Published: July 27, 2021

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.

Journal: Blood

Published: July 23, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026